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ABSTRACT  
 
Exosomes are secreted membrane vesicles that share structural and biochemical 
characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). Exosomes are 
secreted by several cell types and could be involved in intercellular communication and in the 
pathogenesis of infectious and degenerative diseases. The molecular mechanisms of exosome 
biogenesis and secretion are, however, poorly understood. Using a short hairpin RNA 
interference screen, we identified 5 small GTPases of the Rab family that promote exosome 
secretion in HeLa cells, including Rab27a and Rab27b. Silencing of Rab27a or Rab27b 
induced inhibition of MVE docking at the plasma membrane. The size of MVEs was strongly 
increased by Rab27a silencing, whereas MVEs were redistributed toward the perinuclear 
region upon Rab27b silencing, which reduced their density beneath the plasma membrane. 
Thus, the two Rab27 isoforms play different roles in the exosomal pathway. In addition, 
silencing two known Rab27 effectors, Slp4 and Slac2b, inhibited exosome secretion and 
phenocopied silencing of Rab27a and Rab27b, respectively. By showing that inhibition of 
exosome secretion is associated with alterations of MVEs, we demonstrate that exosomes 
mainly originate from MVEs.  
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INTRODUCTION 
 
Exosomes are membrane vesicles secreted into the extracellular space by numerous cell types, 
of hematopoietic and non-hematopoietic origins1-4. These small vesicles (of diameters ranging 
from 50 to 100 nm) enclose cytosol and have a membrane orientation similar to that of the 
plasma membrane. Exosomes secreted by different cell types display a common protein 
composition, mostly including proteins from the endocytic system, the plasma membrane and 
cytosol but excluding proteins from other intracellular organelles, especially nucleus, 
mitochondria, endoplasmic reticulum and the Golgi apparatus. Additionally, exosomes 
contain a set of proteins specific of the cell type from which they originate and that are 
probably important for their extracellular functions.  
The release of these vesicles was originally described to take place during reticulocyte 
maturation as a mechanism to expel obsolete proteins, such as the transferrin receptor5, 6. 
However, it is currently recognized that exosomes are produced by almost all cell types and 
that they could play diverse roles, mostly related with intercellular communication. For 
example, exosomes derived from antigen presenting cells are enriched in Major 
Histocompatibility Complex (MHC) class II, MHC class I and in co-stimulatory molecules, 
and are capable of efficiently inducing T cell responses both in vitro and in vivo when 
injected into mice7-9. T lymphocytes also secrete exosomes that could play a role in inducing 
cell death or antigen presentation10, 11. Activated platelets release both large microvesicles 
(above 100 nm in diameter) and exosomes that may function in signalling and adhesion at 
sites of vascular injury12.  
In addition, these vesicles have been implicated in the pathogenesis of several diseases. For 
instance, virus or prion-infected cells secrete exosomes bearing the capacity to infect other 
cells and therefore, they may participate in pathogen dissemination13, 14. Moreover, β-amyloid 
peptides are released with exosomes from neuroblastoma cells and could, therefore, 
contribute to neurodegeneration in Alzheimer’s disease15. Finally, exosomes derived from 
cancer cells can participate both in the induction of anti-tumor immune responses, and in 
tumor-induced immunosuppression in vivo, depending on the tumor model studied or the 
physiological state of the patient16-18.  
The physiological functions actually played by exosomes in vivo remain, however, 
hypothetical, because all the published reports were based on the purification and 
concentration of these vesicles from cell cultures or biological fluids. Conclusive 
 4
demonstration that in vivo exosome secretion plays a role in any physiological process has 
not been possible so far, due to the lack of tools to specifically inhibit or increase their 
secretion. Indeed, the molecular mechanisms of exosome secretion are not completely 
understood. 
Evidence collected during the last 20 years suggests that in most cell types, exosomes 
correspond to secreted intraluminal vesicles (ILVs) of MVEs4. ILVs are formed by inward 
budding of the limiting membrane of MVEs into the lumen of these endosomes19. The 
observation by electron microscopy (EM) of fusion profiles between MVEs and the plasma 
membrane, with the consequent release of ILVs as exosomes, has been to date the strongest 
evidence of the endosomal origin of exosomes6-8. Nevertheless, in some cell types, such as T 
lymphocytes, exosomes bud at the plasma-membrane from endosome-like domains20. 
Therefore, identification of the molecular machinery responsible for the control of the 
intracellular trafficking of MVEs and their fusion with the plasma membrane is of crucial 
importance for understanding key aspects of exosome secretion.   
Most intracellular transport pathways are controlled by conserved families of cytosolic 
proteins, including the Rab family of small GTPases. Rab proteins control different steps of 
vesicular trafficking, including budding, motility, docking to and fusion of different vesicular 
transport intermediates with acceptor membranes. Almost 70 Rabs and Rab-like proteins have 
been identified in human cells21. Their restricted distribution to specific compartments within 
the cell is consistent with their proposed role in regulating specific membrane trafficking 
steps. Rab proteins cycle between an “active state” (GTP-bound) in which they are associated 
to specific intracellular membranes, and an “inactive state” (GDP-bound), in which most Rabs 
dissociate from the target membranes and are released in the cytosol. In the active state, Rabs 
recruit a wide range of specific effector proteins that are required to carry out their diverse 
roles22. 
Since members of the Rab family of GTPases functionally participate in different steps of 
intracellular membrane trafficking, both along the endocytic and the secretory pathways, we 
analyzed here the roles that the different Rab proteins could specifically play in exosome 
production or secretion, using the human HeLa cell line. To this end, an shRNA-based screen 
targeting human Rabs was performed. We observed that knocking-down five Rab proteins 
(Rab2b, Rab9a, Rab5a, Rab27a and Rab27b) inhibited exosome secretion without major 
modifications in the secretion of soluble proteins through the regular secretory pathway. The 
role played by two of the identified proteins, the Rab27 subfamily members, was studied in 
further detail at the subcellular and molecular levels. Here we show that Rab27a and Rab27b 
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serve a common function in MVE docking to the plasma membrane, but also play different 
and non-redundant roles in the MVE pathway of HeLa cells. In addition, we observed that 
silencing of two known effectors of Rab27, Slp4 and Slac2b, phenocopied silencing of, 
respectively Rab27a and Rab27b, and that Rab27a and Slp4 co-localized on some MVEs, 
suggesting a preferential interaction between these two proteins for exosome secretion.  
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RESULTS 
 
 
Semiquantitative detection of exosomes in cell culture supernatants 
To allow large-scale screening of molecules specifically involved in exosome secretion, we 
developed a quantitative FACS-based assay allowing simultaneous detection of exosomes and 
of proteins secreted through the classical secretory pathway, in small volumes of cell culture 
supernatants. The HeLa B6H4 tumor cell line, which stably expresses the transactivator 
CIITA (which drives expression of all genes of the MHC class II family, including HLA-DR) 
and a secreted form of chicken ovalbumin (OVA), was used for this assay. These cells secrete 
soluble OVA through the classical secretory pathway, and HLA-DR-positive exosomes: these 
two molecules can thus be used as reporters of alterations of either type of secretion. Briefly, 
exosomes present in cleared cell culture supernatants were captured onto latex beads coated 
with antibodies to CD63, a tetraspanin strongly enriched in late endosomes and exosomes23. 
Exosome-bearing beads were analyzed by FACS after staining with either anti-HLA-DR and 
anti-CD81 fluorescent antibodies (CD81 is another tetraspanin abundant on exosomes)7, 23, or 
Annexin V (which binds to the phosphatidyl-serine (PS) present at the surface of exosomes)24  
(Fig. 1A). Membrane vesicles with a diameter ranging from 50 to 100 nm and with the typical 
cup-shaped morphology of exosomes were detected by electron microscopy (EM) on the 
surface of the beads (Fig. 1B). As expected, exosome detection was dependent on the number 
of exosome-secreting cells present in the wells (Fig. 1C, D), with a threshold of sensitivity of 
75,000 cells/well. To assess the specificity of this assay for exosomes, as opposed to other 
secreted membrane vesicles originating from the plasma membrane, supernatants from 
apoptotic cells (which are known to secrete abundant apoptotic blebs) were tested. The FACS 
signals obtained with these supernatants were significantly lower than those obtained using 
supernatants from living cells (Fig. 1E). We conclude that this assay allows the specific 
detection of a population of CD63/HLA-DR/PS-positive membrane vesicles produced by 
living cells, corresponding to exosomes.  
Soluble OVA in cell culture supernatants was detected using beads coated with anti-OVA 
antibodies and subsequently stained with a secondary anti-OVA fluorescent antibody (see 
Supplementary information, Fig. S1). This methodology allowed the quantitative detection of 
OVA, with a sensitivity of 30,000 cells/well. The detection of OVA in the supernatants of 
cells in which apoptosis was induced by UV-irradiation was significantly lower, as compared 
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to live cells.  Altogether, these assays allow the simultaneous quantification of both exosomes 
and OVA in very small volumes of culture supernatants collected from 96-well plates.  
 
Role played by members of the Rab GTPase family in exosome secretion 
 
In order to identify proteins involved in exosome secretion, a lentiviral shRNA library 
targeting 59 members of the Rab GTPase family was screened using the methodology 
described above as readout. Variability of the signals for exosome and OVA secretion 
obtained in control cells expressing a scrambled shRNA were below 20%, as shown in figure 
2A. Candidate genes that induced a significant modification in the secretion of exosomes  but 
not in the secretion of OVA were selected if at least two different shRNAs (out of the three to 
five that target each individual gene) induced a similar phenotype.  
Some examples of Rab proteins that were not considered as hits in the screen because did not 
fulfil the selection criteria are shown in Fig. 2B. For instance, silencing of a Rab associated 
with the secretory pathway, Rab6a (Golgi) inhibited the secretion of OVA but did not affect 
exosome secretion. In contrast, inhibition of two endocytic Rabs, Rab7 (late endosome) or 
Rab11a (recycling endosome), modified neither exosome nor OVA secretion significantly.  
Following the primary screen, 19 Rab proteins that modified exosome production were 
selected. These candidates were re-evaluated in a second round of the screen performed in 
independent triplicate plates. The Rab proteins that yielded consistent results between 
replicates and between the two independent screens were chosen for a final confirmation step. 
The inhibition of the corresponding mRNAs was evaluated by qPCR and the genes for which 
most shRNA modified concomitantly the phenotype and the mRNA expression level, were 
finally selected. This analysis resulted in a final number of 5 Rab proteins whose inhibition by 
shRNA consistently resulted in decreased exosome secretion (Fig. 2C): Rab2b, Rab5a, Rab9a, 
Rab27a and Rab27b. 
With the exception of Rab2b (which has been associated with the early secretory pathway25, 
but is phylogenetically close to endocytic Rabs such as Rab4, Rab14 and Rab1126), the other 
selected Rabs have been previously associated with endocytic functions, confirming the 
postulated endosomal origin of exosomes. In particular, Rab27a and Rab27b are two highly 
homologous Rab proteins (71% amino acid identity27) encoded by different genes, which 
have been associated before with lysosome-related organelles. Here, we observe their 
involvement in a constitutive secretion process, previously postulated to result from the fusion 
of MVEs with the plasma membrane, by a cell type non-specialized in secretion. This 
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observation led us to further analyze the mechanism of inhibition of exosome secretion by the 
two isoforms of Rab27. Decreased exosome secretion by cells expressing the Rab27a or 
Rab27b specific shRNA was further confirmed using annexinV staining of exosome-coated 
beads (Fig. 2D), thus indicating that the reduction in exosome secretion was not due to an 
alteration of the sorting of HLA-DR and CD81 to exosomes. 
 
Rab27a and Rab27b silencing inhibit exosome secretion without modifying their protein 
composition 
 
The inhibition of exosome secretion in cells knocked down (KD) for Rab27a and Rab27b 
observed with the FACS-based assay described above, was confirmed by standard techniques 
of exosome purification previously described28. First, cells transfected with shRNA#3 for 
Rab27a or shRNA#1 for Rab27b were amplified to produce a large volume of supernatant. 
Expression of the respective genes (supplementary information, Fig. S2A) were specifically 
and significantly downregulated in these cells. Exosomes were purified from their supernatant 
by differential ultracentrifugation28. The total amount of secreted exosomes, as determined by 
total exosomal proteins measured by Bradford (Fig. 3A), or the FACS-based assay (Fig. 
S2B), was significantly reduced in both KD cell populations, as compared to control cells. 
Therefore, these results confirm and validate the results obtained in the screen using a small 
volume of cell culture supernatant.  
To investigate whether the protein composition of exosomes secreted by Rab27a and Rab27b 
KD cells was modified, purified exosomes were analyzed by immunoblotting. First, 
exosomes purified from the supernatant of the same number of secreting control or KD cells 
were loaded on a gel and blotted with antibodies against molecules enriched in exosomes, as 
well as with the ER-marker heat shock protein gp96 (as a control for the purity of the 
exosome preparations). The inhibition of exosome secretion by Rab27a-KD cells was 
evidenced by a significant reduction in the signal obtained after blotting with anti-HLA-DR, 
CD63, tsg101, and hsc70 antibodies (Fig. 3B). A similar decrease, although less pronounced 
(Fig. 3B), was observed when purified exosomes secreted by Rab27b-KD cells were 
analyzed. Nevertheless, all these proteins were detected in exosomes from KD cells when 
similar amounts of exosomal proteins where loaded on the gel (Fig. 3C). These results 
suggest that the amount of purified exosomes, rather than their protein composition is 
modified in the Rab27a and Rab27b KD cells. In addition, EM observation of exosomes 
secreted by Rab27a- and Rab27b-KD cells showed that, although they were produced to a 
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lesser extent, their size and morphology were similar to that of the exosomes produced by 
control cells (Fig. 3D).  
Altogether, these data show that the loss of function of either Rab27a or Rab27b results in a 
reduction of the amount of exosomes released in the cell-culture supernatant, but modifies 
neither their protein content nor their morphology.  
 
Different phenotypes of MVEs are observed in Rab27a and Rab27b  KD cells 
 
To gain further insight into the mechanisms responsible for the reduced secretion of exosomes 
observed in Rab27a and Rab27b KD cells, the subcellular distribution and the morphology of 
MVEs in these cells were then investigated using CD63 as a marker. We reasoned that if the 
secretion of exosomes was blocked, the compartment from where exosomes are secreted 
should accumulate intracellularly. In order to evaluate this possibility, the proportion of 
intracellular vs. surface CD63 was measured by FACS analysis. Permeabilized or non-
permeabilized cells were labelled using anti-CD63 antibody to quantify the total and the 
surface CD63, respectively. In Rab27a KD cells, the expression of CD63 at the cell surface 
was not modified, whereas staining of total CD63 was significantly increased, as compared to 
control cells. This result indicates that in Rab27a KD cells there is an intracellular 
accumulation of CD63 (Fig. 4A). In contrast, in Rab27b KD cells, neither total nor surface 
CD63-stainings were significantly modified (Fig. 4A). These results indicate that in the 
absence of Rab27a, CD63 accumulates in internal compartments, whereas the absence of 
Rab27b does not induce such accumulation. 
The subcellular distribution of CD63 was then analyzed by immunofluorescence imaging 
(Fig. 4B, C). In control and Rab27a KD cells, the CD63-positive MVEs appeared 
homogenously distributed throughout the cell. However, silencing of Rab27a induced a 
statistically significant increase in the size of the CD63-positive compartments (Fig. 4B upper 
and middle panels, Fig. 4C). In sharp contrast, Rab27b KD cells displayed a characteristic 
asymmetrical perinuclear accumulation of CD63-positive organelles, but without striking 
alteration of the size of these organelles, as compared to control cells (Fig. 4B lower panel, 
Fig. 4C). The structure and morphology of MVEs were then analyzed by EM in cells 
immunogold labelled with anti-CD63 and anti-HLA-DR antibodies (Fig. 4D). Consistently 
with the immunofluorescence observations, the MVEs from Rab27a KD cells were 
significantly larger (Fig. 4D, right panel) than those from control cells. In contrast, in Rab27b 
KD cells, MVEs showed a clustered distribution (not shown) and they were smaller than 
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those of control cells (Fig. 4D). We conclude that although both Rab27a and Rab27b impair 
exosome secretion, the loss of function of each of these proteins induced different phenotypic 
changes in the size and distribution of CD63-positive MVEs, suggesting that both proteins 
play different roles in the pathway. 
 
Rab27a and Rab27b have different subcellular localizations 
 
Since loss of function of Rab27a and Rab27b resulted in very different morphologies of 
MVEs, we asked whether these two proteins could function in the same or different 
compartments. Thus, the subcellular localization of these two proteins in HeLa B6H4 cell line 
was analyzed by immunofluorescence. As endogenous Rab27a and Rab27b cannot be easily 
detected by immunofluorescence because of low levels of expression, GFP-tagged proteins 
were transiently expressed and then analyzed by 3D-deconvolution imaging. Rab27b-GFP 
presented a perinuclear distribution, mainly concentrated at the trans-Golgi network area, as 
defined by the presence of Rab6 (Fig. 5A right panel) and TGN46 (data not shown). Rab27b 
was also distributed surrounding a subpopulation of CD63-positive compartments (Fig. 5A, 
right panel). In contrast, Rab27a-GFP presented a predominant donut-like pattern, 
surrounding CD63-positive compartments. As opposed to Rab27b, Rab27a colocalized with 
neither Rab6 (Fig. 5A, left panel) nor TGN46 (data not shown) positive compartments.  
The distribution of GFP-tagged Rab27a and Rab27b was further analyzed by EM. Rab27a 
was associated with the limiting membrane of MVEs. It was also present in the membrane of 
vesicular structures closely apposed to these compartments, possibly corresponding to 
transport intermediates (data not shown). Rab27b was observed in the membrane of Golgi 
stacks and in vesicles located in the TGN area, as well as in the limiting membrane of MVEs 
that were in close proximity to the Golgi apparatus (Fig. 5B).  
To determine whether the two proteins were associated with the same or different CD63-
positive compartments, Rab27a-mCherry and Rab27b-GFP were expressed simultaneously 
and cells were analyzed by immunofluorescence. Consistent with the data observed in cells 
transfected with each single protein, both Rab27a and Rab27b were partially associated with 
CD63-positive compartments (Fig. 5C), but Rab27b was predominantly in a perinuclear area 
with partial colocalization with TGN46  (data not shown). Four groups of CD63-positive 
organelles could be identified based on their association with the Rab27 isoforms: most 
organelles were Rab27a-/b-, about 1/5 were Rab27a+/b-, and less than 10% were either 
Rab27a+/b+, or Rab27a-/b+.   
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These findings collectively indicate that Rab27a and Rab27b show a differential subcellular 
distribution: Rab27b predominantly presents an asymmetrical perinuclear distribution in the 
TGN area and a minor localization onto CD63-positive compartments. In contrast, Rab27a is 
preferentially associated with CD63-positive MVEs.  
 
Rab27a and Rab27b silencing reduce docking of MVE to the plasma membrane 
 
To further analyze the process of exosome secretion from MVEs in Rab27 KD cells, we used 
total internal reflection fluorescence microscopy (TIRFM). The penetration depth of the 
evanescent field was set to 150 nm to image the subplasmalemmal region. Interestingly, in 
this subplasmalemmal area, 30% or 40% of CD63-positive compartments were labeled with 
respectively Rab27b-GFP and Rab27a-GFP (data not shown), strengthening the idea that the 
two Rab27 isoforms could play a role at a late stage of the exosome secretion process. We 
thus analyzed the dynamics of GFP-tagged CD63 compartments in live cells (Fig. 6, 
Supplementary movies 1-3, Fig. S3). The density of CD63-positive vesicles in the 
subplasmalemmal area was significantly lower in Rab27b KD than in control cells (Fig. 6A). 
This observation is consistent with the perinuclear relocalization of MVEs observed by 
standard immunofluorescence microscopy (Fig. 4B), and suggests that Rab27b participates in 
the transport of MVEs toward the cell periphery or in their retention near the plasma 
membrane. In addition, in both Rab27a and Ra27b KD cells, CD63-positive vesicles were 
significantly less present at the periphery of the cell footprint (Fig. S3A), suggesting that  both 
Rab27a and Rab27b regulate the distribution of MVEs in this region of the cell.  
The movements of CD63-positive compartments present at the cell periphery were then 
monitored by TIRFM and analysed in detail, by tracking individual trajectories29. No exocytic 
events could be captured, suggesting that these events are rare. However, several different 
types of movements could be analyzed. Examples of movements are shown in Supplementary 
Movies 1-3: some vesicles moved rapidly, others displayed slow diffusive movements, while 
others were almost immobile. The diffusion coefficient (Dxy), an index of mobility, was 
calculated from Mean Square Displacement analysis of single trajectories using a rolling 
analysis window as previously described29. Vesicles with long-range movements display high 
Dxy values, whereas vesicles that move around a limited area by diffusion  or that are 
immobile display low Dxy. As shown in Fig. 6B, CD63-positive compartments moved with 
significantly higher diffusion coefficients in Rab27a- or Rab27b-KD cells than in controls 
(p<0.0001, Mann-Whitney test computed on 499, 415, and 528 trajectories from control, 
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Rab27a- and Rab27b-KD cells respectively), and in Rab27b-KD than in Rab27a-KD cells 
(p=0.006). This result suggests that the restriction in vesicle motion characteristic of the 
docking process that precedes exocytosis 29-31 could be altered in Rab27a and Rab27b KD 
cells. To test this hypothesis, we performed a detailed analysis of the mobility of CD63-
compartments. To set a threshold value below which vesicles could be considered as 
immobile, we plotted the distribution of instantaneous Dxy values (Fig. S3B). A major peak 
comprising the lowest values was centered around 1x10-4 µm2/s (i.e. the average Dxy of 
immobilized latex beads under our experimental conditions30). Thus, vesicles presenting a Dxy 
less than three times this value were considered as immobile. Mean Dxy were thus categorized 
following this first criterion of docking (Fig. 6C). In both Rab27a and Rab27b-KD cells, the 
percentage of immobile structures was significantly lower than in control cells, suggesting 
that docking could be affected. Detailed analysis of the behavior of the enlarged CD63-
positive structures observed upon Rab27a silencing (see Fig. 4B) showed that 82 % of them 
displayed a mean Dxy > 3 x 10-4 µm2.s-1 with a median Dxy of 14.9 ± 5.9 x 10-4 µm2.s-1 (50 
structures from 5 cells). These enlarged MVEs induced by Rab27a silencing were thus not 
attached at the plasma membrane. 
To distinguish bona fide vesicle docking from other processes, we measured the 
duration of immobilization events (Dxy < 3 x 10-4 µm2.s-1) along trajectories and used it as a 
second criterion of docking. The percentage of vesicles that were immobilized during their 
whole trajectory was reduced by Rab27a and Rab27b silencing, whereas the percentage of 
vesicles never immobilized was increased (Fig 6D). To better characterize this process, 
survival curves of the distribution of immobilization times were constructed (Fig. 6E). The 
best fit was obtained with two exponentials, which is consistent with the existence of two 
different processes. The short-lasting component may reflect transient tethering to the plasma 
membrane but also phases of slow diffusion. Long-lasting immobilization periods are most 
probably due to stable attachment to the plasma membrane. Using this refined criterion of 
docking, we conclude that Rab27a and Rab27b silencing reduced both the number (N2 = 0.25 
and 0.28 docking event/trajectory in Rab27a and Rab27b, respectively, compared to 0.44 in 
controls), and the characteristic time (τ2 = 10.1 and 9.3 s in Rab27a and Rab27b, respectively, 
compared to 15.5 s in controls) of docking events. Since Rab27a and Rab27b silencing also 
reduced the amount of vesicles present in the TIRFM area (Fig. 6A), the overall effect on the 
number of docked vesicles per surface area was decreased in both cases by 60-70 %. 
Altogether, these analyses show that silencing of either Rab27a or Rab27b significantly 
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decreased the occurrence and the stability of CD63-positive compartment docking to the 
plasma membrane. 
Another alteration, in addition to the docking defect, was observed in Rab27b-KD cells. 
Indeed, whereas analysis of the trajectories in all types of cells showed an important number 
of vesicles moving rapidly along linear axes (a typical behavior of vesicles propelled along 
microtubules30), the proportion (data not shown) and velocity (Fig. 6F) of these movements 
were increased in Rab27b KD (but not in Rab27a-KD) cells. This behavior accounts for the 
increased proportion of structures with a high mean Dxy (>20 x 10-4 µm2.s-1) (Fig. 6C) 
observed in Rab27b KD. Rab27b thus also probably regulates negatively long-range 
movements of MVEs in the subplasmalemmal region. 
 
 
Slp4 and Slac2b are two Rab27 effectors involved in exosome production 
 
Rab proteins exert their numerous functions by interacting with multiple effectors. Some of 
the known Rab27 effectors have the capacity to interact with both isoforms, whereas for other 
effectors it is not clearly established if they possess a preferential interaction with one of the 
two isoforms. To identify Rab27 effector proteins involved in the exosome pathway, a new 
shRNA screen targeting these proteins was carried out.  
First, the level of expression of all known Rab27 effector proteins in HeLa B6H4 cells was 
analyzed using qPCR. This analysis revealed that 7 out of the 11 Rab27 effector proteins were 
expressed in HeLa B6H4 cells (supplementary Table 1). Subsequently, 6 of the genes that 
were expressed in this cell line were silenced with up to five specific shRNAs and 
quantification of exosomes was performed in cell culture supernatants using the FACS-based 
assay.  
Cells KD for Slac2b (or exophilin-5), Slp4 (or granuphilin) and Munc13-4 exhibited a 
significant reduction in exosome secretion, in at least 2 different shRNAs out of the 4-5 
hairpins that target each gene (Fig. 7A). In the cells transduced with shRNAs against Slp4 and 
Slac2b, the level of exosome secretion paralleled the level of mRNA expression (Fig. 7B). In 
contrast, in the case of Munc13-4, although shRNAs #1, 2 and 3 decreased both exosome 
secretion and mRNA levels, the shRNAs 4 and 5 strongly inhibited mRNA expression 
without affecting exosome secretion (Fig. 7A,B), suggesting off-target effects of the shRNA. 
Consequently, only Slac2b and Slp4 were chosen for further analysis, although a role of 
Munc13-4 in exosome secretion cannot be ruled out. In addition to reducing exosome 
 14
secretion, knock down of the effectors induced an increase in OVA secretion (Fig. 7A), 
suggesting that they also play Rab27-independent roles in the conventional secretion 
pathway. 
To characterize the protein composition of exosomes secreted by the KD cells, large-scale 
cultures of cells expressing lentiviruses #4 (Slac2b) or #1 (Slp4) where set up. Specific 
decrease of Slp4 at the protein level was confirmed by immunoblotting (Fig. 7C). We could 
not, on the other hand, specifically detect Slac2b by Western blot in B6H4 cell lysates, 
probably due to the low overall level of expression. Next, exosomes secreted by the same 
amount of cells were purified from cell culture supernatants by ultracentrifugation and then 
analyzed by western blot with antibodies against CD63, tsg101, HLA-DR and gp96 (Fig. 7D). 
A significant reduction in the amount of CD63, HLA-DR and tsg101 secreted in exosomes 
was observed in Slp4 and Slac2b KD cells. These results show that two Rab27 effectors, Slp4 
and Slac2b, are positive regulators of exosome secretion in HeLa B6H4 cells.  
 
Slp4 and Slac2b KD are phenocopies of Rab27a and Rab27b KD cells, respectively  
 
The distribution and morphology of CD63-positive compartments was then studied in Slac2b 
and Slp4-KD cells. Total and surface distribution of CD63 was first analyzed by FACS using 
permeabilized or non-permeabilized cells, respectively (Fig. 7E). An intracellular 
accumulation of CD63 was observed in Slp4-KD cells, which was comparable to that 
observed in Rab27a-KD cells (Fig. 4A). In contrast, Slac2b-KD cells did not show an 
accumulation of CD63 either at the cell surface or intracellularly. Immunofluorescence 
analysis showed that Slp4-KD cells presented enlarged CD63 compartments distributed 
throughout the cell, a phenotype that clearly resembled that observed in cells KD for Rab27a 
(Fig. 7F left and middle panels). In contrast, Slac2b-KD cells exhibited an asymmetrical 
perinuclear accumulation of CD63-positive vesicles of normal size, as compared to control 
cells, mimicking the phenotype observed in Rab27b KD cells (Fig. 7F, right panel). 
Altogether, loss of function of Slp4 and Slac2b induces phenotypes that, in terms of exosome 
secretion as well as morphology and distribution of MVEs, highly resemble the phenotypes 
observed in cells KD for Rab27a and Rab27b, respectively. This observation suggests that 
Slp4 is the effector linked to the function of Rab27a, and Slac2b is the effector required to 
achieve Rab27b function.  
The preferential association of the two Rab27 effectors with each Rab27 isoform was then 
investigated by immunofluorescence in cells co-transfected with T7-tagged Slp4 or Slac2b 
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and GFP-tagged Rab27a or Rab27b. Slp4 colocalized with Rab27a on donut-like structures 
containing CD63 (Fig. 8A, top panel). In contrast, no colocalization was observed between 
Slp4 and Rab27b, which labelled different CD63-positive structures (Fig. 8A, bottom panel).  
The Rab27a/Slp4 interaction was also confirmed by the observation that Slp4 protein level 
was decreased in Rab27a KD (but not in Rab27b KD) (Fig. 8B), whereas its mRNA level was 
increased (Fig. 8C), suggesting a stabilizing interaction of Rab27a and Slp4 proteins. Due to 
low level of expression of the endogenous Slac2b, which could not be detected by the 
available antibodies, and to poor expression of a T7-Slac2b construct in our cell line, we 
could neither determine its intracellular distribution nor its preferential association with 
Rab27b. 
Thus, silencing of either Rab27a or Slp4 induces similar phenotypes, and we showed a 
topological colocalization and a biochemical interaction between these two proteins. These 
observations thus suggest that these two proteins function together in the MVE and exosome 
pathway of HeLa cells. By contrast, although silencing of Slac2b induces a phenocopy of 
Rab27b-KD cells, we could not demonstrate, for technical reasons, the functional interaction 
between these two proteins.  
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DISCUSSION 
 
 
Three major results are presented here. First, we have set up an assay allowing medium-scale 
screens of the molecular machinery specifically involved in exosome secretion. Second, using 
this assay, we identified a few Rab family members, including Rab27a and Rab27b, that play 
a role in exosome secretion. Third, we found that Rab27a and Rab27b serve both common 
and different roles, most likely via the Slp4 and Slac2b effector proteins respectively, in the 
intracellular trafficking of multivesicular endosomes leading to exosome secretion.  
The identification of Rab molecules that at the same time induce strong morphological and 
topological alterations of CD63-positive MVEs and prevent exosome secretion, demonstrates 
for the first time that MVEs represent the major source of secreted exosomes. Previous 
elegant EM studies6, 7 showing fusion profiles between the limiting membrane of MVEs and 
the plasma membrane and liberation of the ILVs into the extracellular environment had 
shown that MVE exocytosis could account or exosome secretion. But these observations 
could not exclude other mechanisms, such as budding from the plasma membrane or fusion of 
other internal compartments. In addition, the relative contribution of each possible mechanism 
could not be evaluated. Here, by reducing mRNA expression of Rab27 genes to less than 20% 
of the control, we observed 50 to 70% reduction of exosome secretion, thus demonstrating 
that more than 50% of secreted exosomes originate from MVEs. Moreover, these 
observations confirm that late endocytic compartments represent bona fide secretory 
compartments. Several other Rabs, in addition to Rab27, were identified in this study as being 
potentially involved in exosome secretion. Most of them are known to participate in 
trafficking in the endocytic pathway32, 33, thus supporting the endosomal origin of exosomes: 
Rab9 associates with late endosomes and orchestrates retrograde trafficking to the TGN, Rab5 
functions at the level of early endosomes. Finally, Rab2 is generally described in association 
with the intemediate compartment between endoplasmic reticulum and Golgi apparatus, but in 
phylogenetic trees, it is closer to Rab4, Rab11 and Rab1426, i.e. Rabs associated with the 
endocytic pathway. On the other hand, other Rabs associated with the endocytic system, such 
as Rab7 or Rab11, did not modify exosome secretion in HeLa cells. These observations 
suggest that a specific subset of the endocytic system participates in the generation of 
exosomes. 
Rab27a and Rab27b have been previously involved in the regulated secretion of 
compartments of Golgi origin, such as secretory granules of neuroendocrine34, pancreatic35 
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and parathyroid acinar cells 36. Moreover, Rab27 participates in the secretion of lysosome-
related organelles, such as mast cell secretory granules37, platelet dense granules38, and 
cytolytic granules of T lymphocytes39. In this study, we found that Rab27a and Rab27b play a 
key role in exosome secretion by promoting the targeting of MVEs to the cell periphery and 
their docking at the plasma membrane.  
The two Rab27 isoforms were initially thought to play identical roles40: transgenic expression 
of Rab27b in melanocytes deficient for Rab27a could rescue a wild-type melanosome 
phenotype, thus suggesting functional redundancy between the two proteins. More recent 
observations, however, suggested that Rab27a and Rab27b play non-redundant roles in the 
distribution and biogenesis of secretory granules of mast cells37 and platelets38, respectively. 
Interestingly, we observed that in the HeLa cell line, Rab27a and Rab27b  have similar effects 
on MVE docking at the plasma membrane, but perform different and non-redundant tasks in 
the exosomal pathway. Involvement of Rab27 in docking has been previously shown, for 
example in neuroendocrine cells, where Rab27a promotes secretory granule docking by 
recruiting Myrip and Myosin Va (Desnos C., Huet S., Fanget I. and Darchen F., unpublished 
data)29.  
Rab27b silencing induced clustering of CD63-compartments in the perinuclar area and 
strongly lowered the density of the vesicles present in the subplasmalemmal region, 
suggesting that it mediates MVE retention at this peripheral location. Moreover, the fewer 
vesicles localized beneath the plasma membrane presented a higher frequency of movements 
along microtubules with an increased velocity, suggesting that Rab27b mediates the transfer 
of MVEs from microtubules to the actin-rich cortex. A similar function has previously been 
shown to be performed by Rab27 in neuroendocrine cells34, and in melanocytes, where  
Rab27a promotes the retention of melanosomes (another lysosome-like organelle) at the cell 
periphery, and the subsequent transfer of melanin to keratinocytes41, 42. In addition, the 
smaller size of MVEs observed by EM in Rab27b-KD cells may result from a reduced 
residency time at the cell periphery where MVE maturation could occur. Alternatively, the 
accumulation of Rab27b in the Golgi area suggests that this Rab could participate in the 
transfer of membranes from TGN to MVEs, as previously proposed43. As a result, immature 
MVEs may not be properly delivered and retained at the cell periphery. 
In contrast, Rab27a silencing strongly increased the size of MVEs but had moderate effect on 
their intracellular distribution. Two possible modes of action of Rab27a can be envisioned: 
(1) Rab27a is required for docking, and in its absence, vesicles fuse with each other instead of 
fusing with the plasma membrane. Thus, enlargement of MVEs may be related to their 
 18
residency time beneath the plasma membrane; (2) Rab27a prevents fusion of CD63-positive 
compartments retained in the subplasmalemmal region with each other or with other vesicular 
intermediates, and its absence leads to the formation of enlarged compartments whose size 
physically impairs docking to the plasma membrane. 
In addition, we show here that silencing of the Rab27 effectors Slp4 and Slac2b phenocopies  
the silencing of Rab27a and Rab27b, respectively. Furthermore, we could evidence a specific 
functional association of the synaptotagmin-like protein Slp4 with Rab27a, but not Rab27b, in 
HeLa cells. We propose that Slp4 is involved in the docking event regulated by Rab27a 
leading to exosome secretion in HeLa cells. The preferential interaction between Rab27b and 
Slac2b in HeLa cells could not be demonstrated here for technical reasons. However, previous 
studies have demonstrated that Slac2b preferentially interacts with Rab27b in vitro44. Further 
studies assessing the preferential interactions of Rab27 effectors with their respective Rabs 
will have to validate these observations. In addition, the involvement of other effectors in the 
docking process mediated by both Rab27 proteins is possible. Munc13-445, members of the 
synaptotagmin-like family46-48 and Myrip29, which have been proposed to function in vesicle 
docking, are good candidates. Our data on Munc13-4 and Slp2 remain ambiguous and further 
work is needed to test this possibility. 
Finally, we must stress that this work was performed using the HeLa cell line. Although HeLa 
is the most widely studied model for cell biology-related questions, the physiological 
processes at work in this cell type may not be identical to those of other cell types. However, 
mouse dendritic cells deficient for both Rab27a and Rab27b secrete half the amount of 
exosomes than their wild-type counterparts (Supplementary Figure S4) and our preliminary 
data suggest that silencing of Rab27a in a mouse tumor cell line also leads to reduced 
exosome secretion (A. Bobrie, M.O. and C.T., unpublished data). Thus, these observations 
stress the importance of the Rab27 subfamily in exosome secretion by other cell types. 
Nevertheless, further work will be required to decipher the precise mechanism of exosome 
secretion by these other cell types. 
Overall, the possibility to specifically inhibit exosome secretion without affecting the regular 
secretory pathway of soluble proteins opens the way to manipulate their secretion in vivo. For 
instance, inhibition of exosome secretion by tumor cells growing in vivo, or by dendritic cells 
upon pathogen or tumor encounter in vivo, will allow to demonstrate whether these vesicles 
are required for initiation and/or maintenance of immune responses to tumors or pathogens. 
The new tools identified by our screen will thus pave the way for answering the long-lasting 
question of the physiological functions played by exosomes secreted in vivo. 
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METHODS 
 
Cells and reagents 
 
HeLa-CIITA cells49 were stably transfected with pcDNA3 encoding the OVA cDNA fused to 
the signal peptide of lactadherin18, and a subclone named HeLa B6H4 was selected. These 
cells were cultured in DMEM containing 4.5 g glucose/l (Invitrogen, Paisley, Scotland) 
supplemented with 10% fetal calf serum (Abcys), 2 mM glutamine, penicillin/streptomycin 
(100 IU/ml and 100 µg/ml, respectively), 300 µg/ml hygromycin B (Calbiochem, La Jolla, 
CA) and 500 µg/ml of geneticin (Gibco-Invitrogen). For exosome production, cells were 
cultured in “exosome-depleted medium”, i.e. complete medium depleted of FCS-derived 
exosomes by overnight centrifugation at 100,000 g28. 
Plasmids: for GFP fusions: pEGFPC3-Rab27a50, pEGFPC3-Rab27b27, pEGFP-bos-CD6351, 
pT7-Slp452. For mCherry-Rab27a, mcherry was amplified from pcDNA3.1mcherry53 with 
primers (GCG CGGTAC CGC ATG GTG AGC AAG GGC GAG) and (ATG GAC GAG 
CTG TAC AAGGGA GGA ATG TCG GAT GGA GAT TA), and Rab27a from pEGFPC3-
Rab27a 27 with primers (GCG CGG ATC CTC AAC AGC CGC ATA ACC C) and (ATA 
ATC TCC ATCCGA CAT TCC TCC CTT GTA CAG CTC GTC CAT). The two products 
were used as a template for a second round of PCR with primers (GCG CGG TAC CGC ATG 
GTGAGC AAG GGC GAG and GCG CGG ATC CTC AAC AGC CGC ATA ACC C). The 
resulting product was digested with Kpn1 and BamH1 and ligated into a similarly cut vector 
pCMVMyc41, resulting in pCMV-myc-mCherry-Rab27a.  
Lentiviruses expressing shRNA specific for the choosen genes were obtained from the RNAi 
consortium (TRC) and produced as previously described54. 
Antibodies: for FACS analysis : mouse anti-human CD63 (FC-5.01, Zymed) and goat anti-
OVA (ICN) for coupling to aldehyde sulfate latex 4 μm beads (Invitrogen), PE-conjugated 
mouse anti- HLA-DR (L243, BD), anti-CD81 (BD), rabbit anti-OVA (Sigma) coupled to 
FITC according to manufacturer instruction (Pierce), mouse anti-CD63 followed by 
Alexa488-coupled goat anti-mouse (Molecular Probes). For immunoblotting: anti tsg101 
(Santa Cruz), gp96 (Stressgen), CD63 (Zymed), HLA-DR (clone 1B5), Alix (BD), hsc70 
(Stressgen), Rab27a (clone 4B1250), rabbit polyclonal antibodies to Rab27b38, Slp436, 
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Slac2b36. For immunofluorescence and immunoEM : mouse mAb anti-CD63 (Zymed), rabbit 
polyclonal anti-Rab6 clone C19 (Sant Cruz), DAPI (Molecular Probes), rabbit anti-GFP 
(Invitrogen).  
 
Immunoadsorbtion and detection of exosomes by FACS 
 
Anti-human CD63 or anti-OVA antibodies were coupled to 4 μm beads following the 
manufacturer instructions. Briefly, 35 μg of antibody were coupled to 1x108 beads in MES 
buffer overnight at room temperature. Remaining free activated groups were blocked with 
PBS-4% BSA (30 min RT) and beads were stored in PBS with 0.1 % glycine and 0.1% 
sodium azide.  
Cell culture supernatants were cleared from cell debris by successive centrifugations at 1,200 
rpm for 5 min and 4,000 rpm for 20 min. Hundred μl of cleared supernatants were incubated 
with 20,000 anti-CD63 and 20,000 anti-OVA coupled beads overnight at room temperature 
(with shaking at 6,500 rpm). Beads were washed twice in PBS 2% BSA and incubated with 
PE-conjugated anti HLA-DR and anti-CD81 and FITC-coupled anti-OVA (all at 1:100 
dilution) for 30 min on ice. Beads were washed twice in annexin V buffer (BD Biosciences) 
and incubated with APC-conjugated annexin V (1/10) for 10 minutes. Stained beads were 
acquired on a FACSCalibur (BD Biosciences) and data were analyzed with FlowJo software 
(Tree Star, Ashland, OR). Threshold of negative staining was obtained with beads incubated 
with unconditioned medium, and for each culture condition, arbitrary units (A.U.) of exosome 
or OVA secretion were calculated as % of positive beads x MFI of positive beads. 
 
Lentiviral infection and screening procedure 
 
HeLa B6H4 cells were plated in 96 well round-bottom plates at 2,500 cells per well with 10 
μl of virus plus 8 μg/ml polybrene and the plates were centrifuged at 2,250 rpm for 90 
minutes. Infection medium was replaced with fresh complete medium. Puromycin was added 
at a final concentration of 5 μg/ml at day 2. Medium was replaced with exosome-depleted 
medium at day 4. Supernatants were collected 48 h later for OVA and exosome 
quantification, and the amount of live cells in each well was determined using the Cell titer 
blue reagent viability assay (Promega). Both OVA and exosome secretions were normalized 
to the number of viable cells present in the wells, and only wells with a minimal cell number 
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of 75,000 cells/well were analyzed. In each experiment, the basal level of exosome or OVA 
secretion (= control) was calculated as either A.U. of cells transduced with control scrambled 
shRNA, or mean of A.U. of one entire plate. A candidate gene was defined as a hit if two or 
more shRNAs modified A. U. of exosome secretion, in duplicate, by more than one standard 
deviation from the control. Results are presented as percent of A.U. of control. 
 
Quantitative RT-PCR 
 
RNAs were isolated from each well at day 5 after lentiviral infection with the Qiagen RNeasy 
Mini Kit and 200 ng were reverse transcribed with SuperScript II (Invitrogen) according to 
the manufacturer’s directions. 1/10th of cDNA was used for each PCR reaction, performed in 
absolute QPCR ROX MIX (Abgene) on iCycler (BioRad). Primers used for GAPDH 
amplification were: GAPDH_F: GAG TCA ACG GAT TTG GTC GT and GAPDH_R: TTG 
ATT TTG GAG GGA TCT CG. Primer sequences for each gene were either retrieved from 
Primer Bank (http://pga.mgh.harvard.edu/primerbank/) or designed using Primer3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). Cycle thresholds (Ct) were 
normalized to Ct of GAPDH and fold enrichments were calculated as compared to the control 
shRNA-transduced cells values.  
 
Exosome purification 
 
Exosomes were recovered from the supernatant of cells cultured for 48 hours in depleted 
medium. Exosomes were purified by filtration on 0.22-μm pore filters, followed by 
ultracentrifugation at 100,000g as described28. In each exosome preparation, the concentration 
of total proteins was quantified by Bradford assay (BioRad, Marnes la Coquette, France).  
 
Electron microscopy  
 
Exosomes fixed in 2% paraformaldehyde (Carlo Erba, Rodano, Italy) were loaded on 
Formwar/carbon-coated EM grids. Samples were post-fixed in 1% glutaraldehyde, contrasted 
and embedded as previously described28.  
For immunolabeling, cells were fixed with 2% paraformaldehyde in 0.2 M phosphate buffer 
pH 7.4 for 2 h at room temperature. Fixed cells were processed for ultrathin sectioning and 
immunolabeling as described previously28. EM samples were observed at 80 kV with a 
 23
CM120 Twin Phillips electron microscope (FEI company, Eindoven, The Netherlands). EM 
negatives were scanned at 400 dpi with a HI-SCAN drum scanner (Eurocore, Heidelberg, 
Germany) and processed with ColorBrain 3.1 software (Eurocore) and Adobe Photoshop 8.0 
software (Adobe, San Jose, CA). Quantification of the surface of MVBs was performed on at 
least 40 CD63-positive multivesicular compartments present in randomly taken pictures 
analyzed using the iTEM software. 
 
Immunoblotting 
 
Total proteins were obtained from cells lysed in 50 mM Tris, pH 7.5, 0.3 M NaCl, 0.5% 
Triton X-100, 0.1% sodium azide, with a cocktail of antiproteases (Roche), and cleared from 
nuclei by centrifugation at 13,000 rpm for 5 min. Protein extracts from cell lysates or 
exosomes were subjected to separation by SDS-PAGE on 4%–12% gradient gel and blotted 
on Immobilon (Millipore). Membranes were processed for immunoblotting using BD 
chemoluminescence blotting substrate (Roche) according to the manufacturers' directions. 
Images were acquired using Chemidoc XRS (BioRad), intensity of the bands was quantified 
using QuantityOne software (Biorad) and results were expressed as the ratio with control 
cells.  
 
Transfections  
 
For transient transfection experiments, cells were electroporated using a Bio-Rad gene pulser 
II as described previously49. Briefly, 8 x 106 cells were transfected at 200 V and 975 µF with 
up to 25 µg of the different expression vectors and completed with the pcDNA3 plasmid to 
reach a total of 30 µg of DNA per electroporation.  
 
Flow Cytometry 
 
For surface labelling, cells were stained with antibodies diluted in phosphate-buffered saline 
PBS-0.5% BSA on ice. For intracellular + surface staining, cells were fixed with 1% 
paraformaldehyde, before quenching with 0.1 M glycine in PBS, and then permeabilized 
using PermWash reagent (BD Biosciences). Permeabilization buffer was used to dilute 
antibodies or isotype controls and for all washing steps. Cells were acquired on a 
FACScalibur and analyzed using FlowJo software. 
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Immunofluorescence Microscopy 
 
Cells (1 x 105) were seeded on glass coverslips in 24-well plates and allowed to adhere for 
18h. Cells were fixed in 4% (wt/vol) paraformaldehyde, quenched with 0.1 M glycine, 
permeabilized in PBS-0.2% BSA- 0.05% saponin, before incubation with primary and 
fluorescein isothiocyanate (FITC), Cy-3, or Cy-5-coupled secondary antibodies. The 
coverslips mounted with Fluoromount-G (Southern Biotechnology Associates) were 
examined under a motorized upright wide-field microscope (Leica DMRA2) equipped for 
image deconvolution. Acquisition was performed using a x100 objective (PL APO HCX, 1.4 
NA) and a high-sensitive cooled interlined CCD camera (Roper CoolSnap HQ). Z-positioning 
was accomplished by a piezo-electric motor (LVDT, Physik Instrument) and Z-series of 
images were taken every 0.2 µm. Vesicle sizes were calculated with the multi-dimensional 
image analysis (MIA) interface running under MetaMorph (Universal Imaging Corporation) 
that is based on wavelet decomposition55. Briefly, fluorescent objects corresponding to MVE 
were detected as fluctuations that are 20-fold larger than the noise. The watershed function 
was routinely applied in order to precisely detect individual structures in dense regions. The 
diameter of each structure was calculated from the sum of pixels assuming a spherical shape. 
Alternatively, images were acquired with Zeiss confocal microscope (LSM Axivert 720) 
using 63 × 1.4 NA oil immersion objective. Image acquisition and Image analysis were 
performed in the PICT IbiSA Imaging Facility (Curie Institute). Brightness and contrast of the 
images displayed were adjusted for better visualisation. 
Quantification of asymmetrical distribution of CD63-positive vesicles was performed 
manually in a double blind setting, on reconstructed 3D images or on epifluorescent images. 
Asymmetry was defined as a concentration of the CD63-staining in one side of the nucleus 
(covering less than 50% of the nucleus diameter). Percent of cells presenting perinuclear 
asymmetrical distribution of CD63-staining was calculated in four (Rab27-KD) or 2 
(Slp4/Slac2b-KD) experiments. 
 
Evanescent wave fluorescence microscopy (TIRFM) 
 
B6H4 cells stably transfected with Scrambled (Control), Rab27a- or Rab27b-specific shRNA 
were transfected with CD63-GFP-encoding plasmid 36h before analysis by TIRFM. TIRFM 
setup: TIRF imaging was performed on a custom setup as described previously30. The 
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penetration depth δ  (the distance along the z axis over which fluorescence declines e-fold) of 
the evanescent field used to excite the fluorophore was set to 150 nm. Under the conditions of 
observation used, one pixel corresponded to 107.5 nm. In the present work, frames were 
acquired at 10 Hz in stacks of 450 images with an exposure time of 100 ms. Vesicle 
counting: To evaluate their density in the subplasmalemmal region, CD63-GFP structures 
were counted using Multidimensional Image Analysis (MIA55), a custom segmentation 
algorithm based on wavelets. The quantification was performed on entire cells or on regions 
devoid of TGN-like labeling. Vesicle density was expressed as the number of CD63-positive 
structures observed in the evanescent field divided by the size of the cell footprint. Single 
particle tracking and analysis: From stacks of images, 2-dimensional (x, y) trajectories 
were obtained by single particle tracking using MIA software. For each trajectory, the mean 
square displacement (MSD) in the x,y plane was calculated according to Steyer and Almers56. 
The diffusion coefficient Dxy was then calculated as Dxy = s/4 with s being the slope of the 
linear fit of the first 15 points of the MSD curve. To measure Dxy variations along a given 
trajectory, a rolling analysis window of 2.5 s was used as described previously29. Using this 
method, a Dxy value was attributed to each point of the trajectory. An example of a vesicle 
displaying abrupt changes in Dxy, but with tiny fluctuations in Dxy persisting within periods of 
restricted motion, is shown in the inset in Fig. S3B.  Immobilization periods correspond to 
portions of trajectories during which Dxy < 3 x 10-4 µm2.s-1. Survival curves of the distribution 
of immobilization times (i.e. the number of events/trajectory lasting at least the indicated 
immobilization time) were computed for each cell; values obtained in the different cells were 
then averaged. The best fit for the curves was obtained with the sum of 2 exponentials, fN(t) 
=N1 exp(-t/τ1) + N2 exp(-t/τ2), using SigmaPlot (Systat Software, San Jose, CA, USA). N1 and N2 
represent the abundance of each component, τ1 and τ2 their time constants Directed motion. 
Portions of trajectories displaying directed motion were detected by inspection of x vs t and y 
vs t plots and selected using locally written routines (MatLab, The MathWorks, Natick, MA, 
USA). Frame-to-frame rates of movement were calculated and averaged over each period of 
directed motion. 
 
Statistical analyses 
Student’s t-test was used for statistical analyses of the shRNA screen (exosome secretion, 
OVA secretion, mRNA level), and of the immunofluorescence images of CD63-positive 
compartments (size and asymmetrical distribution), ANOVA for protein quantifications on 
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immunoblots, Mann-Whitney for TIRFM analyses  (unless otherwise indicated). Values are 
given as mean ± S.D. in all figures except Fig.6 : mean ±S.E. *= p<0.05, **= p<0.01, ***= 
p<0.001 
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FIGURE LEGENDS 
 
 
Figure 1: Semi-quantitative detection of exosomes in cell culture supernatants. 
(A) Schematic drawing of the technical approach used to selectively capture and stain 
exosomes present in cell culture supernatants by using anti-CD63-coated beads and FACS 
detection. (B) EM image of exosomes present on the surface of anti-CD63-coated beads after 
incubation with supernatant from B6H4 cells. (C) Representative flow cytometry dot-plots 
showing HLA-DR/CD81 (top) and Annexin V (bottom) stainings of exosomes captured by 
beads incubated with supernatants from increasing numbers of cultured cells. Percent of 
positive beads are indicated inside the positive region. (D) Dose-response curve of HLA-
DR/CD81 (left) and Annexin V (right) staining of exosomes captured by beads incubated 
with 66 different supernatants. (E) Specific detection of exosomes secreted by live cells, as 
compared to membranes secreted by apoptotic cells. A total of 50,000 cells either UV-
irradiated or untreated were seeded in a 96-wells plate. After 12h incubation, exosome 
depleted-medium was added and 24h later supernatants were incubated with anti-CD63-
coated beads and analyzed by FACS.   
 
Figure 2: Modulation of exosome and OVA secretion by members of the Rab family. (A) 
Exosome secretion measured as HLA-DR/CD81 staining (Exo, black bars) and OVA 
secretion (white bars) by cells transduced with a control shRNA. Mean±sd of 3 experiments 
(in each experiment, 100% = mean of 3 independent control wells). (B) Exosome and OVA 
secretion and specific mRNA levels of cells transduced with different shRNAs (each bar 
represents a different shRNA) targeting Rab proteins that were not selected as hits in the 
screen, either because neither exosome nor OVA secretion were modified (Rab7, Rab11a) or 
because only OVA secretion was inhibited (Rab6a). Pooled results from duplicate plates in 
one experiment are shown. (C) Exosome and OVA secretion, and specific mRNA levels in 
cells transduced with shRNAs targeting Rab family members that were selected as candidate 
hits because at least 2 shRNAs significantly affected exosome without affecting OVA 
secretion. Pooled results from duplicate experiments (2-3 plates / experiment) are shown. (D) 
Exosome secretion by control and by either Rab27a or Rab27b-KD cells was also evaluated 
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by detection of exposed PS with Annexin V. Arrows indicate the shRNAs that were chosen 
for further characterization. Stars indicate statistically significant differences with control.  
 
Figure 3: Large-scale purification and characterization of exosomes secreted by Rab27a 
and Rab27b-KD cells. (A) The total amount of proteins in the exosomal pellet purified from 
large-scale cultures of stably-transduced cells was quantified by Bradford assay, and reported 
to the number of secreting cells (n=4). (B) Characterization of exosomal proteins by 
immunoblotting. Purified exosomes secreted by equal amounts of control or KD cells were 
analyzed by immunoblotting for the presence of CD63, tsg101, HLA-DR, hsc70, and gp96 
proteins. A total of 130,000 cells were lysed and used for comparison (CL). One 
representative experiment out of four is shown. Histogram shows quantification of signal 
intensity of HLA-DR, hsc70 and tsg101 proteins in exosomes secreted by 20 million KD 
cells, normalized to the value obtained with exosomes from control cells (mean+SD of 3 
experiments for HLA-DR, 4 for tsg101, 2 for hsc70).  (C). Equal amounts of total exosomal 
proteins (quantified by Bradford assay) secreted by either control or KD cells were analyzed 
by immunoblotting for presence of CD63, tsg101, HLA-DR, alix and gp96 proteins, and 
compared to cell lysates. (D) Exosomes purified from cell culture supernatant were negatively 
stained and their size and shape were analyzed by EM. Scale bar, 200 nm. Stars indicate 
statistically significant differences with control. 
 
 
Figure 4: Effect of Rab27a and Rab27b KD on the intracellular distribution of CD63-
positive compartments. (A) Rab27a-KD, Rab27b-KD and control cells were stained with 
anti-CD63 antibodies with (total) or without (surface) permeabilization, and analyzed by 
FACS. Histograms from one representative experiment out of 4 are shown (thin-lined empty 
histograms correspond to isotype-controls). (B) 3D deconvolution fluorescence microscopy of 
control, Rab27a-KD and Rab27b-KD cells stained with anti-CD63 (green) and DAPI 
(nucleus, blue). Scale bar: 17.5 μm. Zoom: x 3.8. (C) Quantification of the morphology and 
distribution of CD63-positive vesicles in control (white bars), Rab27a-KD (black bars) and 
Rab27b-KD cells (grey bars): size of individual CD63-positive compartments (top panel, 
mean+SD of 14, 15 and 20 cells respectively) and percentage of cells with asymmetrical 
distribution (bottom panel, mean+SD of 4 experiments, totalizing 144 Ctrl, 222 Rab27a-KD 
and 277 Rab27b-KD cells) are represented. (D) Electron micrographs of ultrathin 
cryosections of control, Rab27a-KD or Rab27b-KD cells immunogold-labeled with anti-
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HLA-DR (10nm gold) and anti-CD63 antibodies (15nm gold). Scale bar, 250 nm. The surface 
of individual CD63-positive multivesicular compartments was measured on random electron 
micrographs (right panel). Stars indicate statistically significant differences. 
 
 
Figure 5: Differential intracellular distribution of Rab27a and Rab27b. (A) 3D 
deconvolution fluorescence microscopy of cells transiently transfected with GFP-Rab27a (left 
panel) or GFP-Rab27b (right panel) -encoding plasmids, and subsequently stained with anti-
CD63 and anti-Rab6 antibodies. Arrows point at CD63-positive compartments with Rab27-
GFP staining. Scale bar: 10 μm. Zoom: x 2.3. (B) Electron micrographs of ultrathin 
cryosections of Rab27a-GFP (left panel) or Rab27b-GFP (right panel) transfected cells, 
immunogold-labeled with anti-CD63 (15 nm gold) and anti-GFP (10nm gold) antibodies. Bar, 
500 nm. Arrows indicate Rab27 association with the limiting membrane of MVEs and 
arrowheads indicate the localization of Rab27b in the Golgi apparatus area. (C) Confocal 
fluorescence microscopy of cells doubly transfected with mCherry-Rab27a- and GFP-
Rab27b- -encoding plasmids, and subsequently stained with anti-CD63. Scale bar: 10 μm. 
Zoom: x 8. 
 
Figure 6: Effect of Rab27a and Rab27b KD on the mobility of CD63-positive 
compartments in the subplasmalemmal region analysed by TIRFM. (A) Representative 
images of CD63-GFP distribution in control, Rab27a KD and Rab27b KD cells (right panels), 
and density of vesicles in the subplasmalemmal region (left panel) detected by TIRFM (mean 
± s.e for 18 control cells, 19 Rab27a KD cells and 20 Rab27b KD cells, pooled from 2 
experiments). Bar, 5µm. (B) Effect of Rab27a and Rab27b KD on vesicle motion. Mean 
diffusion coefficient (Dxy) values of individual trajectories obtained for at least 400 vesicles in 
control, Rab27a KD and Rab27b KD cells are shown. Red bars: median and interquartile 
ranges. (C) The distribution of Dxy values was computed for each cell on entire trajectories. 
Shown is the mean ± s.e. of Dxy values obtained in cells from 2 independent experiments. 
Note the diminution of the percentage of vesicles with Dxy < 3 x 10-4 µm2/s that are 
presumably docked in Rab27a and Rab27b KD (black bars, control: 12 cells, 499 trajectories; 
grey bars, Rab27a KD: 10 cells, 415 trajectories; white bars, Rab27b KD: 12 cells, 528 
trajectories). (D) Dxy was computed along trajectories using a rolling analysis window. Shown 
is the percentage of vesicles that were always (grey bars) or never (black bars) docked (Dxy < 
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3 x 10-4 μm2/s) in the different conditions. (E) Further characterization of docking events. 
Immobilization periods were detected as in (D) and their duration was measured. Shown are 
logarithmic plots of survival curves for immobilization times (Control, black line; Rab27a 
KD, dashed line; Rab27b KD, gray line). The best fit was obtained with the sum of two 
exponentials. The long-lasting component of the distribution most likely represents vesicle 
docking at the plasma membrane. Rab27a and Rab27b silencing reduced both the abundance 
and the characteristic time of this process. (F) Rab27b KD increases the mobility along 
microtubules. Shown is the mean velocity of vesicles during periods of directed motion.  
 
 
Figure 7: Effect of Rab27 effector proteins on exosome secretion. (A) FACS analysis 
(HLA-DR/CD81 staining) of exosome (left panel) and OVA (right panel) secretion by cells 
infected with viruses containing shRNA to 6 Rab27 effector proteins (3 to 5 viruses per gene). 
Mean +SD of three independent experiments is shown. (B) Specific inhibition of Slp4, Slac2b 
and Munc13-4 gene expression by the different shRNA used, as assessed by qRT-PCR with 
primers specific for each gene. Results from 2 experiments, expressed as percent of mRNA 
expression of control cells are shown. (C) Immunoblot analysis of Slp4 protein level in Slp4 
and Slac2b KD cells. Tubulin was used as a loading control. Immunoblot (left panel) and 
quantification (right panel) are shown. (D) Exosome secretion by B6H4 cells stably 
transduced with lentiviruses bearing scrambled shRNA (Control), Munc13-4 shRNA #2, Slp4 
shRNA #9, or Slac2b shRNA #3.  Exosomes secreted by 9 million cells (Exo), or 30 μg of 
total cell lysates (CL) were analyzed by immunoblotting for presence of CD63, tsg101, HLA-
DR and gp96 proteins. One representative experiment of three is shown. The relative amount 
of HLA-DR and tsg101 secreted in exosomes was quantified by signal intensity measurement 
(right panel). Results are expressed as the mean±SD of ratio to control cells in 3 experiments. 
(E) Slp4 KD, Slac2b KD control cells were stained in parallel with anti-CD63 antibodies after 
permeabilization (total) or not (surface), and analyzed by FACS. Representative histograms 
(left panels, thin-lined empty histograms correspond to isotype-controls) of three independent 
experiments are shown. (F) 3D deconvolution fluorescence microscopy of control, Slp4-, and 
Slac2b KD cells stained with anti-CD63 (green) and DAPI (nucleus, blue). Top part: 
representative images of control, Slp4 KD and Slac2b KD cells (scale bar : 10 μm, zoom : x 
2.5). Bottom part: quantification of the size and distribution of CD63-positive vesicles in 
control (white bars), Slp4-KD (black bars) and Slac2b-KD  cells (grey bars). Size of 
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individual CD63-positive compartments (left panel, mean±SD of 20, 21 and 23 cells 
respectively) and percentage of cells with asymmetrical distribution (right panel, mean±SD of 
2 experiments, totalizing 107 Ctrl, 86 Slp4-KD and 115 Slac2b-KD cells) are represented. 
Stars indicate statistically significant differences with control cells. 
 
Figure 8: Interaction between Slp4 and Rab27a. (A) 3D deconvolution fluorescence 
microscopy of cells doubly transfected with T7-Slp4 and either Rab27a-(left panel) or 
Rab27b-(right panel) GFP-encoding plasmids, and subsequently stained with anti-CD63 and 
anti–Slp4 antibodies. (B-C) Slp4 expression levels in cells KD for either Rab27a or Rab27b. 
Slp4 protein levels were evaluated by immunoblotting in cells KD for either Rab27a or 
Rab27b (B). A representative blot (left panel) and the quantification of three independent 
blots (right panel) are shown. Tubulin was used as a loading control. (C) The level of 
expression of Slp4-specific mRNA in cells KD for either Rab27a or Rab27b was analyzed by 
qPCR.  
 
Supplementary Informations : 
Supplementary Figure S1: Semi-quantitative detection of OVA in cell culture 
supernatants. (A) Representative flow cytometry dot-plots showing the detection of OVA 
present in the supernatants collected from cultures of increasing numbers of cells, after 
capture onto anti-OVA-coated beads and staining with Alexa488-anti-OVA Ig.  (B) Dose-
response curve of OVA staining, obtained by quantification of 66 experimental conditions. 
(C) Comparison of the signal obtained following OVA staining in supernatants collected from 
cultures of either live or UV-irradiated cells collected 24 h after seeding 50,000 cells/well in a 
96-well plate.  
 
Supplementary Figure S2: Further characterization of cells stably transduced with 
Rab27a- or Rab27b-specific viruses. (A) Specific extinction of RAB27A (respectively 
RAB27B) gene expression by Rab27a-specific virus 3 (respectively Rab27b-specific virus 1), 
with no effect on RAB27B (respectively RAB27A) gene expression, as shown by quantitative 
RT-PCR with primers specific for each gene. (B) Representative dot plot showing HLA-
DR/CD81 (top panel) and Annexin V (bottom panel) staining on large-scale supernatants 
from cells transduced with Rab27a-specific virus 3 and Rab27b-specific virus 1. 
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Supplementary Figure S3: Rab27a and Rab27b silencing increase the distance of the 
vesicles to the border of the cells. (A) The areas of the cell footprints (yellow), and of the 
minimal polygon encompassing all vesicles (red), were measured.  Representative images of 
control, Rab27a KD and Rab27b KD cell are shown. (B) Shown is the ratio of the vesicles 
area / total cell area calculated in 23 control cells, 23 Rab27a KD cells and 25 Rab27b KD 
cells. (C) CD63-GFP vesicles were tracked and diffusion coefficients Dxy were computed 
along the trajectories. Shown is the distribution of Dxy pooled from 118 trajectories monitored 
in 7 control cells. Values above 30 x 10-4 µm2.s-1 were omitted. An example of a vesicle 
exhibiting a directed motion (0-5 s) followed by a docking period (5-10 s, 15-25 s) is 
presented in the inset. 
 
Supplementary video-movies:  
Video 1 for a CTRL cell, video 2 for a Rab27a KD cell and Video 3 for a Rab27b KD cell. 
Images were acquired by TIRFM at 10 Hz for 400 s. Movies are accelerated 4 times.  
 
Supplementary Figure S4: Exosome secretion by bone marrow-derived dendritic cells 
(BMDCs) from Rab27a/Rab27b double knock-out mice.  
Dendritic cells were differentiated from bone marrow precursors in the presence of GM-CSF. 
At day 10 after the onset of culture, cells were cultured in exosome-depleted medium for 24h, 
before collection of supernatant and purification of exosomes by ultracentrifugation. WT and 
Rab27a/b-KO cells contained more than 75% of BMDCs, and less than 10% of mature 
BMDCs, as assessed by FACS staining for CD11c, Gr1, MHC Class II. Purified exosomes 
secreted by equal amounts of control or KO cells were analyzed by immunoblotting for 
presence of CD9, tsg101, MFG-E8, Alix, MHC class II, and gp96 proteins. A total of 30 or 10 
μg cells were lysed and used for comparison. One representative experiment of four is shown. 
Histogram shows quantification of signal intensity of CD9, tsg101, MFG-E8, Alix and MHC 
II proteins in exosomes secreted by 5.8 million cells from the KO mice, normalized to the 
value obtained with exosomes from control cells (mean+SD of 4 experiments, with the 
exception of Alix in which only one experiment was analyzed). 
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Supplementary Table 1 : qPCR analysis of Rab27 effector proteins in HeLa B6H4 cells 
 
 
 
Official 
symbol 
Official name Also known as Delta Ct HeLa 
B6H4 cells1 
Delta Ct 
Fon cells 
Expression 
in HeLa 
cells 
SYTL3 synaptotagmin-like 3 Slp3 12 >20 Yes 
RPH3A rabphilin 3A homolog 
(mouse) 
 0 >9 No 
SYTL2 synaptotagmin-like 2 Slp2 >20 13.79 Yes 
UNC13D unc-13 homolog D Munc13-4 >20 ND Yes 
MLPH Melanophilin Slac2a 0.5 7,76 No 
SYTL1 synaptotagmin-like 1 Slp1 0.28 >16.3 No 
RPH3AL rabphilin 3A-like 
(without C2 domains) 
Noc2 >13 >17 Yes 
EXPH5 exophilin 5 Slac2b 10.8 5.63 Yes 
SYTL5 synaptotagmin-like 5 Slp5 14.5 2 Yes 
SYTL4 synaptotagmin-like 4 Granuphilin, 
Slp4
15.85 19.6 Yes 
MYRIP myosin VIIA and Rab 
interacting protein 
Slac2c 0 0 ND 
 
1 Delta Ct was calculated as the difference between the Ct obtained by quantitative RT-PCR 
using primers specific for the indicated gene, minus the Ct obtained in the same conditions in 
samples in which no RT was used for the reverse transcription reaction. 
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